Thursday, 3 September 2020 10:30 am to 11:30 am
Online
Join key officials from the Department for International Trade (DIT) South West and the China Britain Business Council (CBBC) for a comprehensive look at recent developments in the Healthcare and Life Sciences sector in China; exploring what this means for UK companies looking to continue selling to, or advancing further in this fast-growing market.
Who is this webinar for?
This webinar is aimed at South West, experienced exporters. Perfect for UK companies and training providers engaged in pharmaceuticals, medical devices, biotech, CROs and Medtech.
More details: Department for International Trade - China Healthcare Webinar
To register: Register Your Place Now - Click Here
This webinar is the first step for healthcare companies taking a business-focussed approach to reengaging with China and will be followed up by a potential online matchmaking session with Chinese buyers later this year.
Participating companies will also be invited to attend a private online meeting with the CBBC Healthcare Life Science sector lead to discuss in more detail their business plans and ambitions for the Chinese market.
Agenda
10:30 - Introductions – Sarah Hildersley, DIT South West Healthcare Lead
10:35 - Market briefing and update – Jamie Shaw, CBBC Healthcare Life Sciences sector lead
An overview of China’s Healthcare Sector
Step by step guide for UK businesses seeking to sell in China; top tips and navigating barriers to entry
10:55 - Guest experts on IP and the Chinese regulatory requirements
11:15 - Q&A hosted by Sarah Hildersley
11:30 - Close
The current opportunities
China’s healthcare market is the second largest in the world. The sector faces a wide range of challenges: ongoing urban and rural disparity; an ageing population and the rising burden of non-communicable diseases. These difficulties, in line with continued improvement of living standards and rising household disposable income, provide opportunities for UK companies seeking to grow their export business in the Chinese market.
The Chinese government is firmly committed to healthcare development and it remains a key part of the National Strategy, as demonstrated by the Healthy China 2030 planning outline which has an ever liberalising approach to market and regulatory access. This was well evidenced in 2017 for example, with 50% of China’s $52 billion medical device market accounted for by imports. The UK’s capabilities in healthcare-related goods and services provide an ideal match for China’s national healthcare objective.